Oncofertility: preserving generation next. Jill Sullivan MD,PhD First Year Fellow
|
|
- Darren Owens
- 5 years ago
- Views:
Transcription
1 Oncofertility: preserving generation next Jill Sullivan MD,PhD First Year Fellow
2
3 Ataman, L. M. et al., J. of Glob Oncol. 12/23/2015 (epub
4
5 Agenda: Patient Presentations Relevance of Our Discussion Today Population at Risk of Infertility Recommended Strategies ASCO 2013 Update Cost Does Ethnicity/Race Impact Oncofertility?
6 Patient: A 42 yo G1P1 caucasian female PMHx: Psoriasis, Rosacea, otherwise healthy PFHx: Mother deceased Breast Cancer 55 yoa, dx at 47 Soc: Former light smoker quit 20 years ago, negative Etoh/illicits Menarche 14, AFC 34, 6 mos. Fertility treatment, no radiation exposure Dx: T1cNXMX ER+ PR+ HER2 Multifocal Invasive Ductal Carcinoma BRCA 1/2 Negative
7 Patient: B 28 year old Hawaiian/Korean Male PMHx: Anxiety and Tobacco use PFHx: Negative for solid or hematologic malignancy Soc: tob: 5 pack yr history, negative etoh, illicits Married, no children, steady job. Military: 10 years, 3 tours Iraq/Afghanistan, unknown chemical exposures, unprotected exposure to x-ray Dx: Primary Mediastinal B-cell Lymphoma
8 So what is the relevance of this discussion?
9 130, ,000 new diagnosis of cancer in patients of child-bearing age in 2015 (ages 20-45) 26,000 Breast Cancer ½ Million cancer survivors of reproductive age in the US There is an increased emphasis on Quality of Life Infertility and sexual dysfunction are top survivorship concerns Infertility: variable and unpredictable in duration De Moor, J.S. et al., Cancer Epid Biomarkers Prev, 22(4):
10 ncer & Fertility Concerns: Males Fertility is a major concern among male cancer patients 51% of men with cancer report wanting children in the future 77% of these men are childless at diagnosis 1 91% of oncologists agree sperm banking should be offered to eligible men Only 10% offer sperm banking routinely 2 1. Shover LR, Brey K, et al Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. JCO 20: Schover LR, Brey K, et al Oncologists attitudes and practices regarding banking sperm before cancer treatment. JCO 20: Reprinted with permission from Carey Anders, MD
11 Quinn G.P. et al., J. Oncol Pratice, 11(2):
12 Quinn G.P. et al., J. Oncol Pratice, 11(2):
13 So who is at risk?
14 sk Factors pe and Stage of Cancer e eatments Radiation field and cumulative dose Chemotherapy drug class, duration, dose and combination effect BMT high risk, recommend to every patient of reproductive age. Surgery extent of surgical field e-treatment fertility status of patient Often not known or considered
15 Agarwal et al., Transl Androl Urol 3(1):27-40
16 Agarwal et al., Transl Androl Urol 3(1):27-4
17 Lee S. J. et al., J Clin Oncol. 24:
18 MOTHERAPY: PROBABILITY OF AZOOSPERMIA Disease Non-Hodgkin s Lymphoma Testicular Cancer, MOPP, ChIVPP/EVA, COPP become azoospermic PP cycles results in permanent permia 1 /ABV Hybrid (Cyclophosphamide = mg/m 2 ) develop azoospermia 3 Therapy spermia in 46% rary azoospermia in 33% permia in 21% covery in all patients after 18 months 2 n VAPEC-B, VACOP-B, MACOP- B, VEEP - Normospermia >95% n CHOP Therapy - 30% become permanently azoospermic after therapy 1 n BEP x 2-4 cycles -Temporary azoospermia in most - 50% fully recover after 2 years - 80% recover after 5 years 4 ll SJ, Shalet SM Testicular function following chemotherapy. Human Reproduction Update 7(4): son et al European Journal of Cancer 38: e WL, Ginsberg JP, et al Fertility in males treated for Hodgkin s disease with COPP/ABV hybrid. Pediatric Cancer. 44(2): ll SJ, Shalet SM Spermatogenesis after cancer treatment: damage and recovery. Journal of the National r Institute Monographs 34: Reprinted with permission of Carey Anders, M
19 iation Effects: Males ingle Dose Irradiation: Radiation Dose Stage of Germ Cell Damaged Time to onset of azoo/oligospermia Time to Recovery 0-1 Gy Spermatogonia Oligospermia 100% in 9-18 months 2-3 Gy Spermatogonia Spermatocytes 4-6 Gy Spermatogonia Spermatocytes Spermatids Azoospermia 60 days from time of treatment Azoospermia in 60 days or less 14-49% in months Few Recover > 5 years Radiation to Testes (Pelvic/ Gonadal/TBI) Leydig cell dysfunction at >20 Gy (prepubertal) >30 Gy (adolescents and young adults) 6-8 Gy Spermatozoa Permanent Azoospermia No recovery ractionated Dose Irradiation: Radiation Dose Gonadotoxicity Time to Recovery < 0.2 Gy Normospermia NA Gy Dose-dependent azoospermia months 1.2 Gy Azoospermia Likelihood of No Recovery Reprinted with permission of Carey Anders, MD
20 Lee S. J. et al., J Clin Oncol. 24:
21 diation Effects: Females Ovarian Reserve <2Gy destroys up to 50% immature oocytes >6 Gy generally causes ovarian failure in women > 40 >20 Gy permanent loss of function in pre-puebertal girls Gy total abdominal therapy 97% post-pubertal women experience POF 72% pre-pubertal girls lose ovarian function 2 Uterine Function Impaired growth & blood flow Uterine volume correlates with age at irradiation Patients who do conceive are high-risk Spontaneous abortion (early and late) Preterm delivery Low birth weight babies Hypothalamus/Pituitary Gland Function (Head/Brain/TBI) Gy causes GnRH Deficiency Reduced estradiol and progesterone levels 1. Wallace WH, Thomson AB, et al Predicting age of ovarian failure after radiation to a field that includes the ovaries. International Journal of Radiation Oncology Biol. Phys. 62(3): Critchley HOD, Wallace HW Impact of Cancer on Uterine Function. Journal of the National Cancer Institute Monographs 34: Reprinted with permission of Carey Anders, MD
22 wer Drugs: New Dilemnas E AND PREGNANCY Abruzzese, E. et al., Mediterr J. Hematol Infect Dis 6(1):e
23 r risk for spontaneous abortion and fetal abnormality in TKI use. Abruzzese, E. et al., Mediterr J. Hematol Infect Dis 6(1):e
24 So how do we preserve generation next in our patient population?
25
26 Loren, A.W. et al, J Clin Oncol 31:
27
28
29
30 Fertility Options: Men Before During After Status Sperm Banking X Std Testicular Tissue Freezing X Exp Natural Conception X Std Assisted Reproduction X Std Testicular/Epididymal Sperm Extraction X X X Std Sperm Donation X Std Adoption X Std Reprinted with permission of Carey
31 Sperm Banking and ART Goal is to encourage 3 samples to be banked Patients should allow 48 hours of abstinence between collection In close proximity to a facility and collecting at home, samples should be delivered in sterile cups within an hour No lubrication should be used and the sample should be collected into a sterile cup. Alternate approaches are currently being considered including a comercially available NextGen sperm banking kit Samples are then used with ART: IUI: Intrauterine insemination IVF: in vitro fertilization ICSI: intracytoplasmic sperm injection PGD: pre-implantation genetic diagnosis Agarwal et al., Transl Androl Urol 3(1):27-4
32 rithym for Sperm Preservation Modified from Agarwal et al., Transl Androl Urol 3(1):27-40
33 ~ 10% of samples were utilized by patients, the majority in the first 4 years. Sperm quality varies depending on cancer type with testicular cancer having the lowest concentration and motility Conceptions achieved in 25%, live delivery in ~20% Botchan A. et al.,2013. Asian Journal of Andrology, 15:
34 Patient: B Diagnosis in early October 2015 Referral made to Duke Fertility Clinic Low risk for prolonged infertility Day discharge for sperm banking 9 days after biopsy Started Dose-adjusted R-EPOCH 10 days after biopsy Reports erectile dysfunction, low libido starting at cycle 4 Currently cycle 6, otherwise doing well with good response to therapy and minimal side effects
35 rtility Options: Women Before During After Status Embryo Cryopreservation X X Std Oocyte Cryopreservation X X Std Ovarian Tissue Freezing X X Exp In Vitro Maturation X X Exp Ovarian Transposition X Std Radical Trachelectomy X Std GnRHa X Exp Natural Conception X Std In Vitro Fertilization X Std Donor eggs or embryos X Std Adoption X Std Gestational Surrogacy X Std Reprinted with permission of Carey
36 Patient: A Conditional T1NxMx ER+ PR+ HER2- BRCA- IDC Desired more children; Day of her appointment at Duke Cancer Center she was actually scheduled to discuss IVF with another fertility center. Discussed role of surgery, radiation and chemotherapy Due to multifocal disease, mastectomy recommended Due to ER+ PR+ status recommended Endocrine therapy Recommended proceeding with staging prior to surgery and discussion with fertility group about Letrozole containing ovarian stimulation.
37 Oktay, K. et al., J. Clin Endo & Metab 91(10):
38 Majority of patients completed IVF in planned hiatus between surgery& chemo Mean delay from breast surgery to completion of first IVF cycle: days If six patients who underwent second cycle included: days 81% completed IVF cycles within 8 weeks of breast surgery 42 days between diagnosis & referral to fertility preservation Three patients have thawed embryos: One live birth, one biochemical pregnancy; two live births from fresh letrozole/fsh cycles one year post treatment in patients treated for early stage BRCA Oktay, K. et al., J. Clin Endo & Metab 91(10):
39 Kim, J. et al., J. Clin Endocrinol Metab. Jan 11
40 Kim, J. et al., J. Clin Endocrinol Metab. Jan 11
41 LES method for ovarian stimulation is safe and does not decrease relapse free survival Kim, J. et al., J. Clin Endocrinol Metab. Jan 11
42 osed monitoring and fertility planning for women with CML KI therapy with Imatinib. Abruzzese, E. et al., Mediterr J. Hematol Infect Dis 6(1):e
43 t of Preserving Fertility Banking $ /yr cular Tissue Freezing $10,000 ryo Freezing $12,400/cycle yearly storage reezing $11,900/cycle yearly storage ian Tissue Freezing mplantation Genetic Diagnosis $12,000 + yearly storage $2500/cycle H Analog Treatments $500/month r sperm, eggs or embryos $3,000-5,000 tion (domestic, international, public, private) $2,500-35,000 gacy $20, ,000 Reprinted and modified with permission of Carey Anders, MD
44 Does ethnicity/race impact oncofertility?
45 s in Socioeconomic Disparities: n this study, a higher percentage of caucasian women received FP compared with frican American, Asian or Hispanic females. o eligible Hispanic females received FPC. uggested explanations include ethnic disparities in access to care, clinician erceived economic status, language barriers, health literacy and cultural beliefs egarding oncologic and/or reproducive issues. Goodman, L. R Human Reproduction, 27(7):
46 So How Can We Improve: IDENTIFY PATIENTS AT RISK EDUCATE AND TRAIN OUR PROVIDERS: see next slides for resources KNOW WHERE YOUR FERTILITY CENTER IS: DUKE FERTILITY CLINIC: 5704 Fayetteville Rd. Durham (919) STANDARDIZE PROTOCOL FOR FERTILITY PRESERVATION DISCUSSION IN YOUR CLINICS: RISKS, OPTIONS and REFERRALS. THERE ARE LIMITED STANDARD OPTIONS: KNOW WHAT THEY ARE AND IF YOU CAN GET THEM ACCOMPLISHED BASED ON THE TUMOR GROUP YOU WORK WITH
47 Resources: patient and provider education - patient education - Resource Guide: Family planning and Fertility - ASCO University Focus Under Forty Livestrong/Fertile Hope: online risk calculator isavefertility.org: iapplication
48 zese, E. et al., Mediterr J. Hematol Infect Dis 6(1):e Reference al et al., Transl Androl Urol 3(1): an, L. M. et al., J. of Glob Oncol. 12/23/2015 (epub) an A. et al.,2013. Asian Journal of Andrology, 15: or, J.S. et al., Cancer Epid Biomarkers Prev, 22(4): ie WL, Ginsberg JP, et al Fertility in males treated for Hodgkin s disease with COPP/ABV hybrid. Pediatric Blood Cancer. 44(2): ll SJ, Shalet SM Testicular function following chemotherapy. Human Reproduction Update 7(4): ll SJ, Shalet SM Spermatogenesis after cancer treatment: damage and recovery. Journal of the National Cancer Institute Monograph J. et al., J. Clin Endocrinol Metab. Jan 11. J. et al., J Clin Oncol. 24: , A.W. et al, J Clin Oncol 31: , K. et al., J. Clin Endo & Metab 91(10): er LR, Brey K, et al Knowledge and experience regarding cancer, infertility, and sperm banking in younger male survivors. JCO 20: 18 ver LR, Brey K, et al Oncologists attitudes and practices regarding banking sperm before cancer treatment. JCO 20: son et al European Journal of Cancer 38: G.P. et al., J. Oncol Pratice, 11(2):
49 Special Thanks: Dr. Kim Blackwell Dr. Carey Anders Lindsay Nohr Beck Fertile Hope Dr. Susanna Copland Dr. Carlos DeCastro Dr. Richard Riedel My Fellow Fellows My Family
50
Cancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center
Cancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center Trends in Pediatric Cancer Incidence Rates by Site, Ages Birth to 19 Years, 1975 to 2010.
More information10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.
The purview of pediatrics includes the growth, development, and health of the child and therefore begins in the period before birth when conception is apparent. It continues through childhood and adolescence
More informationOptimizing Fertility and Wellness After Cancer. Kat Lin, MD, MSCE
Optimizing Fertility and Wellness After Cancer Kat Lin, MD, MSCE University Reproductive Care University of Washington Nov. 6, 2010 Optimism in Numbers 5-year survival rate 78% for all childhood cancers
More informationPlanning for Parenthood After a Cancer Diagnosis
Cancer and Fertility Planning for Parenthood After a Cancer Diagnosis If you or someone you love is facing cancer, preserving fertility may be the last thing on your mind. But if you re a woman of childbearing
More informationTestosterone Therapy-Male Infertility
Testosterone Therapy-Male Infertility Testosterone Therapy-Male Infertility Many men are prescribed testosterone for a variety of reasons. Low testosterone levels (Low T) with no symptoms, general symptoms
More informationINTRODUCTION TABLE OF CONTENTS. If you want to become a parent after cancer, we would like to give you the information you need to make that happen.
TABLE OF CONTENTS INTRODUCTION INTRODUCTION 1 MEN Fertility Risks 2 Fertility Preservation Options 3 Possible Fertility Outcomes 4 Parenthood After Cancer Options 5 Important Tips for Men 6 WOMEN Fertility
More informationMelanoma-What Every Woman Need to Know about Fertility and Pregnancy
Melanoma-What Every Woman Need to Know about Fertility and Pregnancy Women diagnosed with melanoma may require counseling for fertility preservation, fertility treatment and safety of pregnancy after treatment.
More informationChapter 4. Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007
Chapter 4 Managing Fertility in Childhood Cancer Patients T.K. Woodruff and K.A. Snyder (eds.) Oncofertility. Springer 2007 The original publication of this article is available at www.springerlink.com
More informationFertility Preservation for Cancer Patients
Fertility Preservation for Cancer Patients Molly Moravek, MD, MPH Director, Fertility Preservation Program Assistant Professor Reproductive Endocrinology & Infertility Department of Obstetrics & Gynecology
More informationOncofertility: The Preservation of Fertility Options for Young People with Cancer
Oncofertility: The Preservation of Fertility Options for Young People with Cancer Teresa K. Woodruff, Ph.D. The Thomas J. Watkins Professor of Obstetrics and Gynecology Northwestern University Feinberg
More informationGuideline for Fertility Preservation for Patients with Cancer
Guideline for Fertility Preservation for Patients with Cancer COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For Informational Purposes
More informationLa preservazione della fertilità in oncologia: il carcinoma mammario come paradigma. Olivia Pagani Centro di Senologia dellasvizzera Italiana
La preservazione della fertilità in oncologia: il carcinoma mammario come paradigma Olivia Pagani Centro di Senologia dellasvizzera Italiana Centro di Senologia della Svizzera Italiana Pregnancy rate after
More informationFertility Preservation. Anne Katz PhD RN FAAN
Fertility Preservation Anne Katz PhD RN FAAN Why is fertility preservation important to YAs after cancer? Normality (Crawshaw & Sloper, 2010) Preference for biologic offspring vs. adoption (Schover 2002)
More informationFertility Preservation By Dr Mary Birdsall Chair, Fertility Associates
Fertility Preservation By Dr Mary Birdsall Chair, Fertility Associates What can you put in the Freezer and why would you? Sperm Embryos Eggs Ovarian Tissue Freezing Sperm 60 years ago first human pregnancy
More informationReproductive function in cancer survivors
Reproductive function in cancer survivors Professor W Hamish Wallace hamish.wallace@nhs.net Symposium 20: Endocrine consequences of childhood cancer treatment Liffey Hall 2, 0905 19 May 2015 CONFLICT OF
More informationClinical Policy Committee
Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments
More informationa nonprofit organization Cancer & Fertility Fast Facts for Ob/Gyns information support hope
a nonprofit organization Cancer & Fertility Fast Facts for Ob/Gyns information support hope table of contents introduction introduction 1 role of the obstetrician-gynecologist cancer screening and diagnosis
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationMale Fertility: Your Questions Answered
Male Fertility: Your Questions Answered Michael S. Neal Scientific Director, ONE Fertility, 3210 Harvester Rd. Burlington, Ontario www.onefertility.com mneal@onefertility.com Outline Assisted Conception
More informationGuideline for Fertility Preservation for Patients with Cancer
Guideline for Fertility Preservation for Patients with Cancer COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For Informational Purposes
More informationEndocrine Late Effects in Survivors of Pediatric SCT
Endocrine Late Effects in Survivors of Pediatric SCT Daphna Hutt Pediatric Hem-Onc & BMT Sheba Medical Center, Israel #EBMT2015 www.ebmt.org Stiller CA (2007). Childhood Cancer In Britain. Oxford University
More informationClinical Policy Committee
Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year
More informationCancer & Fertility: Patient Education Booklet. information suppor t hope
Cancer & Fertility: Patient Education Booklet information suppor t hope 1 table of contents introduction 1 men Fertility Risks 2 Fertility Preservation Options 3 Possible Fertility Outcomes 4 Parenthood
More informationTherapeutic Sperm Banking
Therapeutic Sperm Banking An Option for Preserving Male Fertility Andrology Laboratory and Reproductive Tissue Bank Information For Patients Men undergoing cancer treatment, including certain types of
More informationFertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.
Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art
More informationBank your future: Insemination and semen cryopreservation. Disclosure. Lecture objectives
Bank your future: Insemination and semen cryopreservation Roelof Menkveld, PhD Andrology Laboratory, Department of Obstetrics and Gynaecology, Tygerberg Academic Hospital and University of Stellenbosch.
More informationCancer Fertility. Fertility Options to Consider Before Treatment Begins & Parenthood Options After Cancer
& Cancer Fertility Fertility Options to Consider Before Treatment Begins & Parenthood Options After Cancer If you or someone you care about is faced with a cancer diagnosis, preserving fertility may be
More informationFERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida
FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer
More informationAdoption and Foster Care
GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.
More informationHaringey CCG Fertility Policy April 2014
Haringey CCG Fertility Policy April 2014 1 SUMMARY This policy describes the clinical pathways and entry criteria for Haringey patients wishing to access NHS funded fertility treatment. 2 RESPONSIBLE PERSON:
More informationChapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation
Chapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation Leilah E. Backhus, MD, MS, Laxmi A. Kondapalli, MD, MS, R. Jeffrey Chang, MD, Christos Coutifaris,
More informationDear doctor, what about a baby? Myths and facts
Dear doctor, what about a baby? Myths and facts OLIVIA PAGANI BREAST UNIT AND INSTITUTE OF ONCOLOGY OF SOUTHERN SWITZERLAND IBCSG Background About 15% of patients with BC are diagnosed during their reproductive
More informationFertility Policy. December Introduction
Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services
More informationGynecologic Considerations in Women with FA
Gynecologic Considerations in Women with FA RAHEL GHEBRE, M.D., MPH University of Minnesota Medical School Objectives Recommendation for Gynecologic Care FA girls starting at age 16 should establish a
More informationWHAT IS A PATIENT CARE ADVOCATE?
WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing
More informationPolicy statement. Commissioning of Fertility treatments
Policy statement Commissioning of Fertility treatments NB: The policy relating to commissioning of fertility treatments is unchanged from the version approved by the CCG in March 2017. The clinical thresholds
More information03/14/2019. GnRH Analogs for Fertility Preservation: What are the Data? Educational Objectives. Outline
GnRH Analogs for Fertility Preservation: What are the Data? AHN-JH SKCCC Current Topics in Breast Cancer Symposium Karen Lisa Smith MD MPH Assistant Professor Johns Hopkins Breast and Cancer Program March
More informationPolicy statement. Fertility treatments. This policy is unchanged from the version approved by the CCG in July 2014.
Policy statement Fertility treatments This policy is unchanged from the version approved by the CCG in July 2014. Title Policy statement: Fertility treatments v2.0 Author Jacky Walters Approved by Kingston
More informationBrighton & Hove CCG PLS CONFERENCE Dr Carole Gilling-Smith Medical Director
Brighton & Hove CCG PLS CONFERENCE 2016 Dr Carole Gilling-Smith Medical Director FERTILITY CHALLENGES IN THE NHS A TERTIARY CARE PERSPECTIVE LEARNING OBJECTIVES Understand the pathways through assisted
More informationAge Related fertility Preservation: Should you Consider Multiple Egg Freezing Cycles?
Age Related Fertility Preservation: Should you Consider Multiple Egg Freezing Cycles? Age Related fertility Preservation: Should you Consider Multiple Egg Freezing Cycles? All what we really know for sure
More informationNote: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017.
Fertility Policy 10 July 2017 Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017. Introduction BHR CCGs are responsible
More informationEast and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception
East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2015 1 1. Introduction This policy sets out the entitlement and service that will
More informationPROCEDURES LAPAROSCOPY
PROCEDURES - Further infertility work-up if indicated (ultrasound examination / semen decontamination etc.) - Office Hysteroscopy where indicated - Laparoscopic and /or hysteroscopic surgery where indicated
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number Name of Originator/Author Cross Reference V2 East of England Consortium Commissioning Policy for Fertility
More informationIntrauterine (IUI) and Donor Insemination (DI) Policy (excluding In vitro fertilisation (IVF) & Intracytoplasmic sperm injection (ICSI) treatment)
Leicester City Clinical Commissioning Group West Leicestershire Clinical Commissioning Group East Leicestershire and Rutland Clinical Commissioning Group POLICY DOCUMENT Intrauterine (IUI) and Donor Insemination
More informationNHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs
NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO
More informationApproved January Waltham Forest CCG Fertility policy
Approved January 2015 Waltham Forest CCG Fertility policy Contents 1 Introduction 1 2 Individual Funding Requests 1 2.1 Eligibility criteria 1 2.2 Number of cycles funded 2 2.3 Treatment Pathway 3 Page
More informationFertility Services Commissioning Policy
Fertility Services Commissioning Policy NEE CCG Policy Reference: Where patients have commenced treatment in any cycle prior to this version becoming effective, they are subject to the eligibility criteria
More informationRecommended Interim Policy Statement 150: Assisted Conception Services
Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations
More informationFertility Preservation for Breast Cancer. Elizabeth S. Ginsburg MD Medical Director, ART Program Brigham & Women s Hospital
Fertility Preservation for Breast Cancer Elizabeth S. Ginsburg MD Medical Director, ART Program Brigham & Women s Hospital Learning Objectives To be able to list and describe processes of ovulation induction
More informationCRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE
INFERTILITY & IVF MEDICAL ASSOCIATES OF WESTERN NEW YORK CRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE BUFFALOIVF.COM When you have scheduled your appointment with Dr Crickard or Dr Sullivan to sign
More informationT.K. Woodruff et al. (eds.), Oncofertility, Cancer Treatment and Research 156, 3 DOI / _1.
Chapter 1 Reproductive Health After Cancer Clarisa R. Gracia C.R. Gracia (B) Department of Reproductive Endocrinology and Infertility, University of Pennsylvania, Philadelphia, PA, USA e-mail: cgracia@obgyn.upenn.edu
More informationMedical Late Effects of Childhood Cancer
Medical Late Effects of Childhood Cancer Robert Goldsby Associate Professor of Clinical Pediatric UCSF Late Mortality in 5+ Year Survivors 1.00 US Female US Male Survival function estimate 0.70 0.75 0.80
More informationHALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page
HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION
More informationPolicy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)
Islington CCG Fertility Policy First approved: 29 January 2015 Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018) Introduction Islington CCG
More information21 st Century Infertility Treatment & Access to Care: Fertility Preservation Coverage
21 st Century Infertility Treatment & Access to Care: Fertility Preservation Coverage Joyce Reinecke, JD Executive Director, Alliance for Fertility Preservation My Story Diagnosed at 29 Treatment plan:
More informationFERTILITY AND PREGNANCY AFTER BREAST CANCER LISA KOLP, MD JOHNS HOPKINS SCHOOL OF MEDICINE OCTOBER 2013
FERTILITY AND PREGNANCY AFTER BREAST CANCER LISA KOLP, MD JOHNS HOPKINS SCHOOL OF MEDICINE OCTOBER 2013 SPECIAL THANKS TO DR. MINDY CHRISTIANSON INTRODUCTION About 6-7% of breast cancers are diagnosed
More informationFertility preservation in the (young) cancer patient
Fertility preservation in the (young) cancer patient Professor W Hamish B Wallace University of Edinburgh & Royal Hospital for Sick Children, Edinburgh, Scotland, UK hamish.wallace@nhs.net ESMO Madrid
More informationFemale Health Issues after Treatment for Childhood Cancer
Female Health Issues after Treatment for Childhood Cancer The effects of childhood cancer therapy on female reproductive function depend on many factors, including the girl s age at the time of cancer
More informationOocyte Freezing and Ovarian Tissue Cryopreservation:
Oocyte Freezing and Ovarian Tissue Cryopreservation: Comparing Results of These Two Methods in One Program Dr. César Díaz García cesar.diaz@ivi.uk IVI London 83, Wimpole St. London, UK London Conflict
More informationREPRODUCTIVE HEALTH IN YOUNG ADULT CANCER SURVIVORS
REPRODUCTIVE HEALTH IN YOUNG ADULT CANCER SURVIVORS Laxmi A Kondapalli, MD MSCE Colorado Center for Reproductive Medicine Disclosure The speaker has no financial or other conflict of interest Objectives
More informationPlan Now, Parent Later
Plan Now, Parent Later A GUIDE TO Fertility Preservation Options for Males 1 Authors Lisa Bashore, PhD APRN CPNP CPON Barbara Lockart, DNP APN/CNP CPON Contributors Barb Carr, MSN CPNP Debra Schmidt,
More informationFertility treatment and referral criteria for tertiary level assisted conception
Fertility treatment and referral criteria for tertiary level assisted conception Version Number 2.0 Ratified by HVCCG Exec Team Date Ratified 9 th November 2017 Name of Originator/Author Dr Raj Nagaraj
More informationSHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)
SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs) Policy Recommendation 002: Assisted Conception Services Date of Issue: September 2014
More informationUTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma
UTERINE LEIOMYOSARCOMA Uterine Lms, Ulms Or Just Lms Rare uterine malignant tumour that arises from the smooth muscular part of the uterine wall. Diagnosis Female About Uterine leiomyosarcoma Uterine LMS
More informationA nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients
A nationwide survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients Eric J. Forman, M.D., a Carey K. Anders, M.D., b and Millie A. Behera, M.D.
More informationSt Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16
St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review
More informationSpontaneous recovery of ovarian function and fertility after cancer treatment
Rigshospitalet The Fertility Clinic Copenhagen, Denmark Spontaneous recovery of ovarian function and fertility after cancer treatment Kirsten Tryde Macklon, Ph.D. 5th society of reproductive medicine and
More informationASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE
ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception
More informationDirector of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017
Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services, in Shropshire and Telford and Wrekin Owner(s) Version No. Director of
More informationTrends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction
Trends in Egg Donation Vitaly A. Kushnir MD Center for Human Reproduction Disclosures No relevant financial relationships to disclose CHR views the commercial trade in human oocytes with considerable ethical
More informationBRCA mutation carrier patient: How to manage?
BRCA mutation carrier patient: How to manage? Clinical Case Presentation Katarzyna Sosińska-Mielcarek Department of Oncology and Radiotherapy University Clinical Center Gdansk, Poland esmo.org DISCLOSURE
More informationSymptom Management. Fertility and You
Symptom Management Fertility and You Table of Contents 3 Will cancer impact my ability to have children? 4 How do I talk to my children about preserving their fertility during cancer treatment? 5 What
More informationOnco-fertility. Fertility issues in young women with breast cancer in Japan. National Cancer Center Hospital, Tokyo Chikako Shimizu, MD
Onco-fertility Fertility issues in young women with breast cancer in Japan National Cancer Center Hospital, Tokyo Chikako Shimizu, MD COI disclosure Chikako Shimizu receives contracted research fund from
More informationWhen should I ask my doctor about my fertility?
Preserving Fertility for Men with Cancer Some cancers and their treatments can affect a man s ability to father a child (his fertility). These changes can last for a short time, or may be permanent. This
More informationIVF. NHS North West London CCGs
IVF NHS North West London CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services Adopted by NWL CCGs to be effective from
More informationCOMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.
COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of
More informationINDICATIONS OF IVF/ICSI
PROCESS OF IVF/ICSI INDICATIONS OF IVF/ICSI IVF is most clearly indicated when infertility results from one or more causes having no other effective treatment; Tubal disease. In women with blocked fallopian
More informationSOUTHEND CENTRES FERTILITY CLINICS. FOR APPOINTMENTS CALL , DELHI
SOUTHEND CENTRES DELHI Holy Angels Hospital, First Floor, Basant Lok, Vasant Vihar Saket City Hospital, Mandir Marg, Press Enclave Road, Saket Southend IVF & Fertility Centre, B 362-364, Outer Ring Road,
More informationCOMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES
COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES Version number V2.3 Responsible individual Author(s) Barry Weaver Trish
More informationCOMMISSIONING POLICY. Tertiary treatment for assisted conception services
Final Version COMMISSIONING POLICY Tertiary treatment for assisted conception services Designated providers for patients registered with a Worcestershire GP BMI The Priory Hospital, Birmingham - 1 - Commissioning
More informationClinical Policy: Fertility Preservation Reference Number: CP.MP.130
Clinical Policy: Reference Number: CP.MP.130 Effective Date: 9/16 Last Review Date: 11/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More informationTHRESHOLD POLICY T40 CRYOPRESERVATION OF SPERM, OOCYTES AND EMBRYOS IN PATIENTS WHOSE TREATMENT POSES A RISK TO THEIR FERTILITY
THRESHOLD POLICY T40 CRYOPRESERVATION OF SPERM, OOCYTES AND EMBRYOS IN PATIENTS WHOSE TREATMENT POSES A RISK TO THEIR FERTILITY Policy author: Ipswich & East Suffolk and West Suffolk Clinical Commissioning
More informationNational Fertility Preservation Register: datatabase to help cancer patients with fertility issues
National Fertility Preservation Register: datatabase to help cancer patients with fertility issues by: SUE DUNLEVY NATIONAL HEALTH REPORTER From: News Corp Australia 14 days ago April 20, 2014 8:07PM Time
More informationUpdated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study
Analysis Concept Proposal 1. Study Title Updated Analysis of Non-Surgical Premature Menopause in the Childhood Cancer Survivor Study 2. Working Group and Investigators CCSS Working Group: Chronic Disease
More informationEvidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors.
Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors. Who needs surveillance? Chiarelli et al. Early menopause and Infertility
More informationOncofertility: An Emerging Discipline in Obstetrics and Gynecology
23 CME REVIEWARTICLE Volume 68, Number 8 OBSTETRICAL AND GYNECOLOGICAL SURVEY Copyright * 2013 by Lippincott Williams & Wilkins CHIEF EDITOR S NOTE: This article is part of a series of continuing education
More informationFertility assessment and assisted conception
Fertility assessment and assisted conception Dr Geetha Venkat MD FRCOG Director Pulse Learning Women s health 14 September 2016 Disclosure statement Dr Venkat is a director of Harley Street Fertility Clinic.
More informationSARCOMA/GIST AND FERTILITY
SARCOMA/GIST AND FERTILITY Christine Rousset-Jablonski Medical Gynecologist Léon Bérard Cancer Center, Lyon SPAEN conference, Milan 2018 Fertility/ Pregnancy after cancer A major concern for patients surviving
More informationPOGO SURVIVORS CONFERENCE
POGO SURVIVORS CONFERENCE Dr. Karen Glass MD, FRCS(C), FACOG Director Fertility Preservation Program, CReATe Fertility Centre Assistant Professor, University of Toronto I HAVE NO CONFLICT OF INTEREST.
More informationThe ABC s of Setting Up a Successful Oncofertility Medical Practice
The ABC s of Setting Up a Successful Oncofertility Medical Practice Teresa K. Woodruff, Ph.D. Director, Oncofertility Consortium Kristin Smith, B.A. Fertility Preservation Patient Navigator Brigid Smith,
More informationFertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment
More informationPediatric Grand Rounds - UT Health SA 09/14/2018
Fertility Preservation: Who, What, Why, When and How Glenn L. Schattman, MD Associate Professor The Center for Reproductive Medicine and Infertility Weill Medical College of Cornell University Disclosure
More informationBlackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception
1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationFertility Preservation in Pediatric and Adolescent Oncology
Fertility Preservation in Pediatric and Adolescent Oncology Chris Fryer with special thanks to: Dr S Pritchard at BC Children s Hospital and Dr A Gupta at Hospital for Sick Kids I have no conflict of interest
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationOncofertility: The Story of the Spermatogonial Stem Cell
Oncofertility: The Story of the Spermatogonial Stem Cell James M. Hotaling, MD MS FECSM Co-director Fertility Integrated Practice Unit Asst. Prof of Surgery(Urology) Adjunct Asst. Prof OBGYN University
More informationClinical Policy: Fertility Preservation
Clinical Policy: Reference Number: CP.MP.130 Last Review Date: 09/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and legal information. Description
More informationOVARIAN FUNCTION AFTER CHILDHOOD CANCER
OVARIAN FUNCTION AFTER CHILDHOOD CANCER Practicing through Controversy Diane Puccetti MD Leslie Coker Appiah MD NASPAG April 2018 Objectives Review use and limitations of risk stratification. Understand
More information